With IL-12 prospect nearing clinic, Ankyra inks NCI pact to support cancer pipeline progress
With IL-12 prospect nearing clinic, Ankyra inks NCI pact to [...]
With IL-12 prospect nearing clinic, Ankyra inks NCI pact to [...]
Emergex’s synthetic T-cell adaptive vaccines close in on data in [...]
U2 disbands: In a crushing step back, TG retracts FDA [...]
Dutch courage: Netherlands makes $350M bet on patient-centered preclinical cancer [...]
Game over: Bristol Myers, Nektar end $3.6B immuno-oncology program after [...]
Chutes & Ladders—Former CVS exec Denton, responsible for Aetna merger, [...]
AstraZeneca’s Alexion, Arvinas nab space at future 10-story biotech tower [...]
FDA urges creation of racial, ethnic recruitment plans for clinical [...]
Evelo hits the brakes on atopic dermatitis drug development after [...]
UPDATE: Magenta cuts 14% of staff, trims R&D amid tumultuous [...]